Esketamine Monotherapy Safe, Effective for Resistant Depression: Phase 4 Data - Medscape

Submitted by Anonymous (not verified) on Tue, 07/15/2025 - 09:18

Esketamine Monotherapy Safe, Effective for Resistant Depression: Phase 4 Data  Medscape